Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Non-Current Assets (2021 - 2025)

Core Scientific's Non-Current Assets history spans 5 years, with the latest figure at $1.1 billion for Q3 2025.

  • For Q3 2025, Non-Current Assets changed N/A year-over-year to $1.1 billion; the TTM value through Sep 2025 reached $2.9 billion, changed N/A, while the annual FY2024 figure was $572.0 million, 7.02% down from the prior year.
  • Non-Current Assets for Q3 2025 was $1.1 billion at Core Scientific, up from $664.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.9 billion in Q1 2022 and bottomed at $345.0 million in Q1 2021.
  • The 5-year median for Non-Current Assets is $659.8 million (2023), against an average of $818.2 million.
  • The largest annual shift saw Non-Current Assets soared 449.49% in 2022 before it plummeted 65.2% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $1.7 billion in 2021, then plummeted by 57.05% to $722.6 million in 2022, then dropped by 14.87% to $615.1 million in 2023, then fell by 7.02% to $572.0 million in 2024, then surged by 94.11% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Non-Current Assets are $1.1 billion (Q3 2025), $664.9 million (Q1 2025), and $572.0 million (Q4 2024).